Ventyx Biosciences Inc (NASDAQ: VTYX) is -24.29% lower on its value in year-to-date trading and has touched a low of $1.79 and a high of $11.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VTYX stock was last observed hovering at around $1.97 in the last trading session, with the day’s loss setting it -0.1%.
Currently trading at $1.87, the stock is -14.32% and -16.08% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.3 million and changing -5.08% at the moment leaves the stock -47.59% off its SMA200. VTYX registered -20.76% loss for a year compared to 6-month loss of -60.47%. The firm has a 50-day simple moving average (SMA 50) of $2.2284 and a 200-day simple moving average (SMA200) of $3.567975.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -23.67% gain in the last 1 month and extending the period to 3 months gives it a -5.08%, and is -15.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.86% over the week and 5.93% over the month.
Ventyx Biosciences Inc (VTYX) has around 80 employees, a market worth around $125.52M and $0.00M in sales. Distance from 52-week low is 4.47% and -83.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.81%).
The EPS is expected to grow by 36.44% this year, but quarterly earnings will post � year-over-year.
Ventyx Biosciences Inc (VTYX) Top Institutional Holders
168.0 institutions hold shares in Ventyx Biosciences Inc (VTYX), with institutional investors hold 88.13% of the company’s shares. The shares outstanding are 59.24M, and float is at 53.83M with Short Float at 15.11%. Institutions hold 85.21% of the Float.
The top institutional shareholder in the company is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with over 5.83 million shares valued at $13.47 million. The investor’s holdings represent 9.4284% of the VTYX Shares outstanding. As of 2024-06-30, the second largest holder is CITADEL ADVISORS LLC with 5.76 million shares valued at $13.3 million to account for 9.3133 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 5.25 million shares representing 8.4872% and valued at over $12.12 million, while BLACKROCK INC. holds 7.7174 of the shares totaling 4.77 million with a market value of $11.02 million.
Ventyx Biosciences Inc (VTYX) Insider Activity
The most recent transaction is an insider sale by Krueger Christopher W, the company’s CHIEF BUSINESS OFFICER. SEC filings show that Krueger Christopher W sold 1,651 shares of the company’s common stock on Apr 02 ’24 at a price of $5.40 per share for a total of $8921.0. Following the sale, the insider now owns 0.28 million shares.
Ventyx Biosciences Inc disclosed in a document filed with the SEC on Apr 02 ’24 that Nuss John (CHIEF SCIENTIFIC OFFICER) sold a total of 1,651 shares of the company’s common stock. The trade occurred on Apr 02 ’24 and was made at $5.40 per share for $8921.0. Following the transaction, the insider now directly holds 0.26 million shares of the VTYX stock.
Still, SEC filings show that on Apr 02 ’24, Mohan Raju (CEO AND PRESIDENT) disposed off 4,312 shares at an average price of $5.40 for $23299.0. The insider now directly holds 1,578,250 shares of Ventyx Biosciences Inc (VTYX).
